Harrow Health Q4 2025 Earnings Preview
Source: SeekingAlpha
2026-02-27 17:35:50 ET
More on Harrow Health
- Harrow: Revisiting This Eyecare Growth Story Ahead Of Q4 Update
- Harrow: Flirting With Missing 2025 Revised Guidance
- Harrow: Vevye Replaces Xiidra On Tier 1 Formulary At CVS
- Seeking Alpha’s Quant Rating on Harrow Health
- Historical earnings data for Harrow Health
Read the full article on Seeking Alpha
For further details see:
Harrow Health Q4 2025 Earnings Preview
Harrow Health Inc.
NASDAQ: HROW
HROW Trading
-0.88% G/L:
$36.25 Last:
496,057 Volume:
$35.55 Open:
